p21 can be a barrier to ferroptosis independent of p53

被引:0
|
作者
Venkatesh, Divya [1 ]
Stockwell, Brent R. [1 ,2 ]
Prives, Carol [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] Columbia Univ, Dept Chem, New York, NY 10027 USA
来源
AGING-US | 2020年 / 12卷 / 18期
关键词
p21; ferroptosis; cancer; p53-independent; organ damage; CELL-DEATH; TUMOR-SUPPRESSOR; DOWN-REGULATION; PHOSPHORYLATION; INACTIVATION; METABOLISM; SENESCENCE; RESISTANCE; POTENCY; DISEASE;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Traditionally, the p21 protein has been viewed as limiting cancer progression and promoting aging. In contrast, there are reports that p21 can enhance cancer survival and limit tissue damage, depending on the tissue of origin and type of stressor involved. Here, we provide evidence to support these latter two roles of p21 by exploring its ability to regulate ferroptosis. Ferroptosis is a form of cell death that is associated with certain degenerative diseases, some of which are aging-related. Our results reveal a correlation between p21 protein levels in cell lines that are resistant to ferroptosis (p21 high) versus cell lines that are sensitive and easily undergo ferroptosis (p21 low). We also show that p21 levels themselves are differentially regulated in response to ferroptosis in a p53-independent manner. Further, experimentally altering the abundance of p21 protein inverts the ferroptosis-sensitivity of both resistant and sensitive human cancer cell lines. Our data also indicate that the interaction of p21 with CDKs is crucial for its ability to restrict the progression of ferroptosis. While this study was performed in cancer cell lines, our results support the potential of p21 to aid in maintenance of healthy tissues by blocking the damage incurred due to ferroptosis.
引用
收藏
页码:17800 / 17814
页数:15
相关论文
共 50 条
  • [31] The expression of p53 and p21 in giant cell arteritis.
    Nordborg, E
    Nordborg, C
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S387 - S387
  • [32] Expression of p53 and p21 in bladder carcinoma of Iraqi patients
    Al Chalabi, Rawaa
    Salih, Shahlaa M.
    Saad, Sajid
    Jawad, Hayder
    JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2019, 92 (01): : 34 - 38
  • [33] ABSENCE OF MUTATION IN P21 IN BREAST CANCERS WITH WILDTYPE P53
    EVANS, AA
    PRIMROSE, JN
    ROYLE, GT
    CROOK, TR
    BRITISH JOURNAL OF SURGERY, 1995, 82 (11) : 1572 - 1573
  • [34] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [35] P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21
    Su, L
    Sai, Y
    Fan, R
    Thurston, SW
    Miller, DP
    Zhou, W
    Wain, JC
    Lynch, TJ
    Liu, G
    Christiani, DC
    LUNG CANCER, 2003, 40 (03) : 259 - 266
  • [36] Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence
    Sayama, K
    Shirakata, Y
    Midorikawa, K
    Hanakawa, Y
    Hashimoto, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 179 (01) : 40 - 44
  • [37] EXPRESSION OF P21 IS DEPENDENT ON OR INDEPENDENT OF P53 IN CARCINOMA EX PLEOMORPHIC ADENOMA (UNDIFFERENTIATED AND ADENOCARCINOMA TYPES)
    Tarakji, Bassel
    Baroudi, Kusai
    Hanouneh, Salah
    Nassani, Mohammad Z.
    Alotaibi, Abdullah M.
    Kharma, M. Yaser
    Azzeghaiby, Saleh N.
    POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 286 - 291
  • [38] p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
    Qin, LF
    Ng, IOL
    Fan, ST
    Ng, M
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 424 - 428
  • [39] Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer
    Noske, Aurelia
    Lipka, Sybille
    Budczies, Jan
    Mueller, Kathrin
    Loddenkemper, Christoph
    Buhr, Heinz Johannes
    Kruschewski, Martin
    ONCOLOGY REPORTS, 2009, 22 (01) : 3 - 9
  • [40] p53, p21, and p73 Gene Polymorphisms in Gastric Carcinoma
    Shirai, Osamu
    Ohmiya, Naoki
    Taguchi, Ayumu
    Nakamura, Masanao
    Kawashima, Hiroki
    Miyahara, Ryoji
    Itoh, Akihiro
    Hirooka, Yoshiki
    Watanabe, Osamu
    Ando, Takafumi
    Goto, Yasuyuki
    Hamajima, Nobuyuki
    Goto, Hidemi
    HEPATO-GASTROENTEROLOGY, 2010, 57 (104) : 1595 - 1601